Hulio 40 mg (Adalimumab SOLUTION) 40 MG

HULIO 40 MG is a subcutaneous solution containing adalimumab, used for managing inflammatory conditions. This biosimilar medication offers targeted therapy for various autoimmune disorders.

Strength

40 MG

Manufacturer / TM Owner

BIOSIMILAR COLLABORATIONS IRELAND LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

HULIO 40 MG is primarily used for the treatment of inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It works by targeting specific proteins in the body to reduce inflammation and alleviate symptoms. Patients often wonder, 'What is HULIO 40 MG used for?' This medication is designed to help manage chronic inflammatory diseases that affect joints and tissues.

Side Effects

Common effects of HULIO 40 MG may include injection site reactions, such as redness, swelling, or itching. Some users might experience fatigue, nausea, or mild headaches. These effects vary among individuals and are generally mild to moderate in severity.

Precautions & Warnings

HULIO 40 MG should be handled with care, ensuring proper storage and administration as directed. Patients with infections or a history of allergic reactions should consult their healthcare provider before use. Always follow the prescribed guidelines for subcutaneous injections to minimize risks.

Avoid Interactions

HULIO 40 MG may interact with certain medications, including immunosuppressants and biologics. Alcohol consumption should be moderated, as it can affect the body's immune response. It's important to discuss all current medications with a healthcare provider to avoid potential interactions.

Frequently Asked Questions

HULIO 40 MG is used to manage inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

HULIO 40 MG is administered via subcutaneous injection, typically self-administered after proper training.

Common side effects include injection site reactions, fatigue, nausea, and mild headaches.

HULIO 40 MG may interact with certain medications, so it's important to consult a healthcare provider before combining treatments.

HULIO 40 MG should be stored in a refrigerator between 2°C to 8°C, protected from light and kept out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.